Latest Ratios: P/E Ratio 12.6x · EV/EBITDA 13.3x · ROE 27.7%. (1997–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.7B | $2.2B | $2.4B | $2.1B | $2.2B | $2.9B | $3.2B | $2.1B | $2.7B | $3.8B | $3.1B |
| Enterprise Value | $3.4B | $2.9B | $3.2B | $2.9B | $3.0B | $3.7B | $4.1B | $2.9B | $3.1B | $4.0B | $3.4B |
| P/E Ratio → | 12.57 | 9.84 | 28.52 | — | 124.42 | 19.42 | 21.65 | — | 15.87 | 19.86 | 27.03 |
| P/S Ratio | 1.64 | 1.30 | 1.43 | 1.10 | 1.08 | 1.38 | 1.66 | 1.15 | 1.48 | 2.13 | 1.78 |
| P/B Ratio | 3.28 | 2.57 | 3.18 | 2.79 | 2.08 | 2.52 | 2.95 | 2.26 | 2.26 | 3.21 | 3.06 |
| P/FCF | 13.10 | 10.41 | 19.97 | 19.50 | 12.76 | 13.25 | 14.18 | 10.66 | 16.27 | 16.39 | 15.05 |
| P/OCF | 10.53 | 8.37 | 11.81 | 9.94 | 7.84 | 8.49 | 8.93 | 7.32 | 10.65 | 10.21 | 9.75 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.71 | 1.91 | 1.53 | 1.46 | 1.79 | 2.12 | 1.56 | 1.70 | 2.23 | 1.96 |
| EV / EBITDA | 13.27 | 11.09 | 8.08 | 7.08 | 6.98 | 8.49 | 9.69 | 7.93 | 7.87 | 9.60 | 8.97 |
| EV / EBIT | 12.41 | 11.09 | 16.41 | — | 41.65 | 16.21 | 18.79 | 15.74 | 13.46 | 15.20 | 15.37 |
| EV / FCF | — | 13.72 | 26.76 | 27.09 | 17.32 | 17.11 | 18.13 | 14.47 | 18.62 | 17.21 | 16.55 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.3% | 74.3% | 71.2% | 66.1% | 61.5% | 62.3% | 63.9% | 64.3% | 66.1% | 67.7% | 70.3% |
| Operating Margin | 16.5% | 16.5% | 14.7% | 11.9% | 10.2% | 10.5% | 11.3% | 9.9% | 12.6% | 14.7% | 12.8% |
| Net Profit Margin | 13.2% | 13.2% | 5.0% | -10.7% | 0.9% | 7.1% | 7.6% | -4.1% | 9.3% | 10.7% | 6.6% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 27.7% | 27.7% | 11.3% | -22.4% | 1.6% | 13.3% | 14.6% | -7.0% | 14.2% | 17.5% | 11.1% |
| ROA | 8.4% | 8.4% | 3.1% | -6.9% | 0.5% | 4.4% | 4.5% | -2.4% | 5.8% | 7.1% | 4.1% |
| ROIC | 13.4% | 13.4% | 11.9% | 10.0% | 8.1% | 8.2% | 8.9% | 8.4% | 11.6% | 14.7% | 12.7% |
| ROCE | 15.0% | 15.0% | 13.3% | 11.0% | 8.9% | 9.0% | 9.3% | 8.5% | 11.3% | 13.9% | 11.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.91 | 0.91 | 1.20 | 1.20 | 0.85 | 0.82 | 0.91 | 1.02 | 0.41 | 0.30 | 0.36 |
| Debt / EBITDA | 2.97 | 2.97 | 2.27 | 2.19 | 2.09 | 2.15 | 2.33 | 2.65 | 1.23 | 0.86 | 0.97 |
| Net Debt / Equity | — | 0.82 | 1.08 | 1.09 | 0.74 | 0.74 | 0.82 | 0.81 | 0.33 | 0.16 | 0.31 |
| Net Debt / EBITDA | 2.68 | 2.68 | 2.05 | 1.98 | 1.84 | 1.92 | 2.11 | 2.09 | 0.99 | 0.46 | 0.81 |
| Debt / FCF | — | 3.31 | 6.79 | 7.59 | 4.56 | 3.86 | 3.95 | 3.81 | 2.35 | 0.82 | 1.50 |
| Interest Coverage | 5.91 | 5.91 | 3.72 | -2.82 | 1.88 | 11.59 | 11.90 | 7.29 | 14.09 | 19.86 | 13.86 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.54 | 0.54 | 0.54 | 0.52 | 0.60 | 0.57 | 0.53 | 0.66 | 0.57 | 0.55 | 0.46 |
| Quick Ratio | 0.51 | 0.51 | 0.51 | 0.49 | 0.57 | 0.53 | 0.49 | 0.62 | 0.53 | 0.50 | 0.40 |
| Cash Ratio | 0.10 | 0.10 | 0.10 | 0.10 | 0.12 | 0.10 | 0.09 | 0.22 | 0.11 | 0.19 | 0.07 |
| Asset Turnover | — | 0.65 | 0.62 | 0.69 | 0.65 | 0.62 | 0.56 | 0.58 | 0.61 | 0.63 | 0.66 |
| Inventory Turnover | 22.40 | 22.40 | 21.12 | 24.25 | 25.30 | 21.47 | 16.46 | 14.98 | 17.13 | 14.67 | 10.67 |
| Days Sales Outstanding | — | 53.16 | 49.70 | 43.69 | 56.04 | 58.17 | 58.58 | 61.66 | 62.18 | 43.16 | 40.07 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.7% | 3.4% | 3.2% | 3.7% | 3.6% | 2.7% | 2.4% | 3.6% | 2.8% | 1.9% | 2.3% |
| Payout Ratio | 33.6% | 33.6% | 90.4% | — | 448.5% | 52.1% | 51.9% | — | 45.0% | 38.3% | 63.0% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.0% | 10.2% | 3.5% | — | 0.8% | 5.1% | 4.6% | — | 6.3% | 5.0% | 3.7% |
| FCF Yield | 7.6% | 9.6% | 5.0% | 5.1% | 7.8% | 7.5% | 7.1% | 9.4% | 6.1% | 6.1% | 6.6% |
| Buyback Yield | 3.6% | 4.6% | 2.5% | 2.2% | 1.6% | 1.0% | 0.5% | 2.2% | 2.2% | 1.0% | 1.6% |
| Total Shareholder Yield | 6.3% | 8.0% | 5.7% | 5.9% | 5.2% | 3.7% | 2.9% | 5.8% | 5.1% | 3.0% | 4.0% |
| Shares Outstanding | — | $53M | $55M | $55M | $56M | $57M | $56M | $56M | $58M | $58M | $58M |
Open access transition volatility
Based on reported figures, WLY trades at a forward P/E of 11.47, which appears to discount the company relative to peers like Pearson, likely reflecting investor skepticism regarding the long-term sustainability of its research-heavy business model amidst the ongoing transition toward open access publishing mandates.
The current valuation multiple suggests the market is pricing in significant execution risk regarding the Value Acceleration Plan. Investors should monitor whether the narrowing focus on high-margin research can justify a re-rating toward the higher multiples commanded by more diversified information services peers.
As reported in financial statements, WLY's ROIC has struggled to exceed 4.6% in recent quarters, a trend that suggests the company is currently failing to generate returns above its cost of capital while it navigates the divestiture of lower-margin education service assets and legacy operational overhead.
The persistent gap between invested capital and returns indicates that the company's historical acquisition strategy may have been value-destructive. Future improvement in ROIC will likely depend on the successful realization of synergies from the core research portfolio and the elimination of capital-intensive, non-core business units.
According to recent SEC filings, WLY's cash conversion cycle has fluctuated significantly, ranging from -6 to 32 days over the last ten quarters, which highlights the inherent sensitivity of the publishing business model to the timing of institutional subscription renewals and academic billing cycles.
The variability in the cash conversion cycle suggests that management faces challenges in optimizing working capital, particularly as the revenue mix shifts toward article processing charges. Investors should monitor whether the company can achieve more consistent cash flow generation as it moves away from transactional education services.
Based on quarterly balance sheet data, WLY maintains a current ratio of 0.54, a figure that appears structurally low compared to broader industrial standards and suggests a reliance on consistent, recurring cash inflows to meet short-term obligations without the buffer of significant liquid current assets.
This liquidity profile warrants investigation, as it leaves little room for operational errors or unexpected market shocks. The company's ability to maintain its dividend while managing this tight liquidity position suggests that management prioritizes shareholder returns, though this may come at the expense of balance sheet flexibility.
The P/E ratio is frequently misapplied to WLY because it fails to account for the significant non-cash restructuring charges and goodwill impairments that have historically distorted reported net income, masking the underlying cash-generating capability of the core research publishing and platform business segments.
Analysts should instead focus on EV/EBITDA or P/FCF to better capture the true operational performance of the business. Relying on P/E may lead to an inaccurate assessment of the company's valuation, as it ignores the substantial impact of non-recurring items on the bottom line.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying WLY stock.
John Wiley & Sons, Inc.'s current P/E ratio is 12.6x. The historical average is 24.6x. This places it at the 4th percentile of its historical range.
John Wiley & Sons, Inc.'s current EV/EBITDA is 13.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.2x.
John Wiley & Sons, Inc.'s return on equity (ROE) is 27.7%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 17.4%.
Based on historical data, John Wiley & Sons, Inc. is trading at a P/E of 12.6x. This is at the 4th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
John Wiley & Sons, Inc.'s current dividend yield is 2.67% with a payout ratio of 33.6%.
John Wiley & Sons, Inc. has 74.3% gross margin and 16.5% operating margin. Operating margin between 10-20% is typical for established companies.
John Wiley & Sons, Inc.'s Debt/EBITDA ratio is 3.0x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.